Abstract
The two main complications of central retinal vein occlusion are macular edema and neovascularizations. Intravitreal anti-vascular growth factor and corticosteroid injections are the mainstays of the current treatment of central retinal vein occlusion. In this review, we aimed to summarize the clinical studies of intravitreal ranibizumab in macular edema secondary to central retinal vein occlusion.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
